 SAN JOSE, Calif., Sept. 7, 2021 PRNewswire -- Anixa Biosciences, Inc. NASDAQ: ANIX, a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today the appointment of Pamela D. 